Sponsored by Somnia Anesthesia Services | solutions@somniainc.com | 1.877.795.5799

Somnia Anesthesia's CMO Comments on Misconceptions of Propofol

A recent Somnia Anesthesia Services blog post discusses misconceptions about Propofol and features insight from Robert Goldstein, MD, Somnia's chief medical officer and a board-certified anesthesiologist.

 

The safety of Propofol and its usage is receiving nationwide coverage because of Michael Jackson's death and the manslaughter trial of his personal physician, Dr. Conrad Murray. Dr. Goldstein comments on the drug's safety and use in the blog post.

 

"Propofol is a commonly used anesthetic that is intended to be prescribed and administered by an anesthesiology professional," said Dr. Goldstein, in the blog. "Like any anesthetic, Propofol should not be given until a careful preoperative examination has been completed to evaluate the appropriateness of its use on each individual patient. Once it has been determined to be a viable option for the patient it should be administered only in the proper setting, by proper personnel using appropriate monitoring."

 

More Articles Featuring Somnia:

Somnia Anesthesia to Provide Anesthesiology Services at California's Kaweah Delta Medical Center

Somnia Anesthesia Recognized as a Patient Safety Organization

Somnia Anesthesia Blog Discusses Postoperative Cognitive Dysfunction

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 
Dow Jones 12,369.38 ▼73.11 (-0.59%)
NASDAQ 2,778.79 ▼34.90 (-1.24%)
S&P 500 1,295.22 ▼9.64 (-0.74%)
INDEXDJX:.DJI

Dow Jones

Company ID [INDEXDJX:.DJI] Last trade:12,369.38 Trade time:4:03PM EDT Value change:▼73.11 (-0.59%)
INDEXNASDAQ:.IXIC

NASDAQ

Company ID [INDEXNASDAQ:.IXIC] Last trade:2,778.79 Trade time:5:16PM EDT Value change:▼34.90 (-1.24%)
INDEXSP:.INX

S&P 500

Company ID [INDEXSP:.INX] Last trade:1,295.22 Trade time:4:33PM EDT Value change:▼9.64 (-0.74%)

Subscribe Today

Upcoming Events